2026 (2026)

Market: HKG | Currency:

Address:

📈 2026 Historical Chart

📊 Statistics

💰 Dividend History

No dividend history available.

📅 Earnings & EPS History for 2026

No earnings history available for this symbol.

📰 Related News & Research

• Suntec REIT Q1 2026 Business Update Announcement and Company Overview
  April 3, 2026
  

  Suntec REIT Announces Q1 2026 Business Update Release Date a...

• Mermaid Maritime PLC 2026 Shareholders’ Forum – Financial Review, Global Expansion, and Offshore Energy Market Outlook
  April 3, 2026
  

  Mermaid Maritime PLC Shareholders’ Forum 2026 – Key Investor...

• Penguin Solutions Q2 2026 Financial Results: Net Sales Outlook Raised Amid Strong AI and Memory Demand
  April 2, 2026
  

  Penguin Solutions, Inc. Reports Q2 Fiscal 2026 Results and R...

• Alkami Technology, Inc. Files Form 8-K Announcing No Written or Soliciting Communications – Company Information and Filing Details (March 31, 2026)
  April 2, 2026
  

  Alkami Technology, Inc. Announces Expansion of Board with Tw...

• Hovnanian Enterprises, Inc. 8-K Filing March 31, 2026 – Company Information, Securities, and Shareholder Incentive Plan Details
  April 2, 2026
  

  Hovnanian Enterprises, Inc. — Key Developments from 8-K Fili...

• ON24, Inc. Files 8-K on April 1, 2026 Announcing Merger Agreement and Key Company Information
  April 2, 2026
  

  ON24, Inc. Announces Completion of Merger, Delisting, and Ma...

• WEC Energy Group Investor Update April 2026: Strong Earnings Growth, Clean Energy Initiatives, and Premium Long-Term Returns 17
  April 2, 2026
  

  WEC Energy Group Announces Rate Case Filings and Oak Creek P...

• Broadstone Net Lease Announces Q1 2026 Earnings Release and Conference Call Schedule
  April 2, 2026
  

  Broadstone Net Lease, Inc. Announces Schedule for First Quar...

• Blue Owl Capital Corporation (OBDC) Schedules Q1 2026 Earnings Release and Conference Call for May 7, 2026
  April 2, 2026
  

  Blue Owl Capital Corporation Schedules Q1 2026 Earnings Rele...

• bioAffinity Technologies’ CyPath® Lung Test Sales Surge 146% in Q1 2026, Driven by Growing Adoption for Early Lung Cancer Detection 1
  April 2, 2026
  

  bioAffinity Technologies Reports 146% Surge in CyPath® Lung ...

🔍 View more Reports